The role of recombinant murine IL-12 and IFN-γ in the pathogenesis of a murine systemic Candida albicans infection

Journal of Immunology

Volumn 160, Issue 1, 1998, Pages 284-292

  Lavigne, Liz M ^a   Schopf, Lisa R ^a   Chung, Charles L ^a   Maylor, Rich ^a   Sypek, Joseph P ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; RECOMBINANT INTERLEUKIN 12;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; DISEASE RESISTANCE; EXPERIMENTAL INFECTION; FEMALE; INFECTION SENSITIVITY; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; DNA, COMPLEMENTARY; FEMALE; IMMUNITY, CELLULAR; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; KIDNEY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECOMBINANT PROTEINS; SPLEEN; SURVIVAL ANALYSIS;

EID: 0031883538     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Musial, C. E., F. R. Cockerill, and G. D. Roberts. 1988. Fungal infections of the immunocompromised host: clinical and laboratory aspects. Clin. Microbiol. Rev. 1:349.
2. Saral, R. 1991. Candida and Aspergillus infections in immunocompromised patients: an overview. Rev. Infect. Dis. 13:487.
3. Cole, G. T., A. A. Halawa, and E. J. Anaissie. 1996. The role of the gastrointestinal tract in hematogenous candidiasis: from the laboratory to the bedside. Clin. Infect. Dis. 22:S001.
4. Kaufmann, S. H. E. 1993. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11:129.
5. Sher, A., and R. L. Coffman. 1992. Regulation of immunity to parasites by T cells and T-cell derived cytokines. Annu. Rev. Immunol. 10:385.
6. Puccetti, P., L. Romani, and F. Bistoni. 1995. A Th1-Th2-like switch in candidiasis: new perspectives for therapy. Trends Microbiol. 3:237.
7. + subset expression in murine candidiasis. Infect. Immun. 60:4950.
8. + subset expression in murine candidiasis. J. Immunol. 150:925.
9. Cenci, E., A. Mencacci, R. Spaccapelo, L. Tonnetti, P. Mosci, K.-H. Enssle, P. Puccetti, L. Romani, and F. Bistoni. 1995. T helper cell type 1 (Th1)-and Th2-like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J. Infect. Dis. 171:1279.
10. Romani, L., A. Mencacci, U. Grohmann, S. Mocci, P. Mosci, P. Puccetti, and F. Bistoni. 1992. Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J. Exp. Med. 176:19.
11. Puccetti, P., A. Mencacci, E. Cenci, R. Spaccapelo, P. Mosci, K.-H. Enssle, L. Romani, and F. Bistoni. 1994. Cure of murine candidiasis by recombinant soluble interleukin-4 receptor. J. Infect. Dis. 169:1325.
12. Cenci, E., L. Romani, A. Vecchiarelli, P. Puccetti, and F. Bistoni. 1990. T cell subsets and IFN-γ production in resistance to systemic candidosis in immunized mice. J. Immunol. 144:4333.
13. Romani, L., A. Mencacci, L. Tonetti, R. Spaccapelo, E. Cenci, S. F. Wolf, P. Puccetti, and F. Bistoni. 1994. Interleukin-12 but not IFN-γ production correlates with induction of T helper type-1 phenotype in murine candidiasis. Eur. J. Immunol. 24:909.
14. Romani, L., A. Mencacci, L. Tonetti, R. Spaccapelo, E. Cenci, P. Puccetti, S. F. Wolf, and F. Bistoni. 1994. IL-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J. Immunol. 152:5167.
15. Wolf, S. F., D. Sieburth, and J. Sypek. 1994. Interleukin 12: a key modulator of immune function. Stem Cells 12:154.
16. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251.
17. Murray, H. W. 1990. Gamma interferon, cytokine-induced macrophage activation and antimicrobial host defense in vitro, in animals and in humans. Diagn. Microbiol. Infect. Dis. 13:411.
18. Berton, G., and M. A. Cassatella. 1992. Modulation of neutrophil functions by interferon gamma. In Granulocyte Response to Cytokine: Basic and Clinical Researches. R. G. Coffey, ed. Marcel Dekker, Inc., New York. pp. 437-456.
19. Aida, Y., and M. J. Pabst. 1990. Removal of endotoxin from protein solutions by phase separation using Triton X-114. J. Immunol. Methods. 132:191.
20. Sheehan, D. C., and B. B. Hrapchack. 1987. Theory and Practice of Histotechnology. Batelle Press, Columbus.
21. Schleifer, K. W., H. Filutowicz, L. R. Schopf, and J. M. Mansfield. 1993. Characterization of T helper cell responses to the trypanosome variant surface glycoprotein. J. Immunol. 150:2910.
22. Marletta, M. A., P. S. Yoon, R. Iyengar, C. D. Leaf, and J. S. Wishnok. 1988. Macrophage oxidation of l-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 27:8706.
23. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
24. Tonnetti, L., R. Spaccapelo, E. Cenci, A. Mencacci, P. Puccetti, R. J. Coffman, F. Bistoni, and L. Romani. 1995. Interleukin-4 and -10 exacerbate candidiasis in mice. Eur. J. Immunol. 25:1559.
25. Romani, L., P. Puccetti, A. Mencacci, E. Cenci, R. Spaccapelo, L. Tonnetti, U. Grohmann, and F. Bistoni. 1994. Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with C. albicans. J. Immunol. 152:3514.
26. Green, S. J. 1995. Nitric oxide in mucosal immunity. Nat. Med. 1:515.
27. Vincendeau, P., S. Daulouede, B. Veyret, M. L. Darde, B. Bouteille, and J. L. Lemesre. 1992. Nitric oxide mediated cytostatic activity on Trypanosoma brucei gambiense and Trypanosoma brucei brucei. Exp. Parasitol. 75:353.
28. Nussler, A. K., and T. R. Billiar. 1993. Inflammation, immunoregulation, and inducible nitric oxide synthase. J. Leukocyte Biol. 54:171.
29. Sypek, J. P., C. L. Chung, S. H. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797.
30. Gately, M. K., R. R. Warrier, S. Honasoge, D. M. Carvajal, D. A. Faherty, S. E. Connaughton, T. D. Anderson, U. Sarmiento, B. R. Hubbard, and M. Murphy. 1994. Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo. Int. Immunol. 6:157.
31. Kobayashi, M., L. Fitz, M. Ryan, R. M. Hewick, S. C. Clark, S. Chan, R. Loudon, F. Sherman, B. Perussia, and G. Trinchieri. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170:827.
32. Biron, C., and R. T. Gazzinelli. 1995. Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome. Curr. Opin. Immunol. 7:485.
33. Vazquez-Torres, A., J. Jones-Carson, and E. Balish. 1995. Nitric oxide production does not directly increase macrophage candidacidal activity. Infect. Immun. 63:1142.
34. Xie, Q.-w., H. J. Cho, J. Calaycay, R. A. Mumford, K. M. Swiderek, A. Ding, T. Troso, and C. Nathan. 1992. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225.
35. Vazquez-Torres, A., J. Jones-Carson, T. Warner, and E. Balish. 1995. Nitric oxide enhances resistance of SCID mice to mucosal candidiasis. J. Infect. Dis. 172:192.
36. Garner, R. E., U. Kuruganti, C. W. Czarniecki, H. H. Chiu, and J. E. Domer. 1989. In vivo immune responses to Candida albicans modified by treatment with recombinant murine gamma interferon. Infect. Immun. 57:1800.
37. Qian, Q., and J. E. Cutler. 1997. Gamma interferon is not essential in host defense against disseminated candidiasis in mice. Infect. Immun. 65:1748.
38. Jensen, J., T. Warner, and E. Balish. 1993. Resistance of SCID mice to Candida albicans administered intravenously or colonizing the gut: role of polymorphonuclear leukocytes and macrophages. J. Infect. Dis. 167:912.
39. Jensen, J., T. Warner, and E. Balish. 1994. The role of phagocytic cells in resistance to disseminated candidiasis in granulocytopenic mice. J. Infect. Dis. 170: 900.
40. Ghezzi, P., and C. A. Dinarello. 1988. IL-1 induces IL-1. III. Specific Inhibition of IL-1 production by IFN-γ. J. Immunol. 140:4238.
41. Van't Wout, J. W., J. W. Van der Meer, M. Barza, and C. A. Dinarello. 1988. Protection of neutropenic mice from lethal Candida albicans infection by recombinant interleukin-1. Eur. J. Immunol. 18:1143.
42. Pecyk, R., E. Fraser-Smith, and T. Matthews. 1989. Efficacy of interleukin-1β against Candida albicans infections in normal and immunosuppressed mice. Infect. Immun. 57:3257.
43. Oliviera, I. C., P. S. Sciavolino, T. H. Lee, and J. Vilcek. 1992. Downregulation of inlerleukin 8 expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon. Proc. Natl. Acad. Sci. USA 89:9049.
44. Ohmori, Y., and T. A. Hamilton. 1994. IFN-γ selectively inhibits lipopolysaccharide-inducible JE/monocyte chemoattractant protein-1 and KC/GRO/melanoma growth-stimulating activity gene expression in mouse peritoneal macrophages. J. Immunol. 153:2204.
45. Cassatella, M. A., I. Guasparri, M. Ceska, F. Bazzoni, and F. Rossi. 1993. Interferon-gamma inhibits interleukin-8 production by human polymorphonuclear leucocytes. Immunology 78:177.
46. Spaccapelo, R., L. Romani, L. Tonnetti, E. Cenci, A. Mencacci, G. Del Sero, R. Tognellini, S. G. Reed, P. Puccetti, and F. Bistoni. 1995. TGF-β is important in determining the in vivo patterns of susceptibility in mice infected with Candida albicans. J. Immunol. 155:1349.
47. Clemons, K. V., E. Brummer, and D. A. Stevens. 1994. Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis. Antimicrob. Agents Chemother. 38:460.
48. Magee, D. M., and R. A. Cox. 1996. Interleukin-12 regulation of host defenses against Coccidiodes immitis. Infect. Immun. 64:3609.
49. Zhou, P., M. C. Sieve, J. Bennett, K. J. Kwon-Chung, R. P. Tewari, R. T. Gazzinelli, A. Sher, and R. A. Seder. 1995. IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction IFN-γ. J. Immunol. 155:785.